Inventor

Sarah Pollock

Inventor
Tel Aviv, IL

Overview

19→
Patents
2003–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms24%
C07KPeptides20%
G01NInvestigating or analysing materials by determining their chemical or physical properties20%
C12NMicroorganisms or enzymes12%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
Y02ATechnologies for adaptation to climate change6%
C12YEnzymes4%
A61KPreparations for medical, dental or toiletry purposes2%
C07HSugars2%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology2%
PatentTitleYear
10,597,671Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield, biomass, oil content and/or growth rate20209,487,795'Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield, biomass, oil content and/or growth rate'20169,347,952'Soluble VEGFR-1 variants for diagnosis of preeclampsia'20168,937,220'Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield, biomass, vigor and/or growth rate of a plant'20157,939,634'Polynucleotides encoding polypeptides and methods using same'20117,906,635'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer'20117,842,459'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis'20107,741,433'Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof'20107,714,100'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease'20107,667,001'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer'20107,601,692'MCP-1 splice variants and methods of using same'20097,569,662'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer'20097,553,948'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer'20097,528,243'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer'20097,488,813'Diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof'20097,368,548'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer'20087,345,142'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease'20087,332,569'Brain natriuretic peptide spliced variant'20086,625,545'Method and apparatus for mRNA assembly'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2016Patents assigned to COMPUGEN LTD (16)· patent assignee history
2003–2020Based in Tel Aviv, IL· patent location history
2015–2020Patents assigned to EVOGENE LTD (3)· patent assignee history
2015Patents assigned to DIBER ALEX (1)· patent assignee history
2015Patents assigned to EMMANUEL EYAL (1)· patent assignee history
2015Patents assigned to KARCHI HAGAI (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
COMPUGEN LTD162003–2016
EVOGENE LTD32015–2020
DIBER ALEX12015
EMMANUEL EYAL12015
KARCHI HAGAI12015
Locations
LocationPatentsSpan
Tel Aviv, IL192003–2020